Annual Interest Expense
$1.25 M
-$1.94 M-60.90%
31 December 2023
Summary:
EyePoint Pharmaceuticals annual interest expense is currently $1.25 million, with the most recent change of -$1.94 million (-60.90%) on 31 December 2023. During the last 3 years, it has fallen by -$6.01 million (-82.82%). EYPT annual interest expense is now -82.82% below its all-time high of $7.26 million, reached on 31 December 2020.EYPT Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$0.00
$0.000.00%
30 September 2024
Summary:
EyePoint Pharmaceuticals quarterly interest expense is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.EYPT quarterly interest expense is now -100.00% below its all-time high of $1.84 million, reached on 30 September 2020.EYPT Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$0.00
$0.000.00%
30 September 2024
Summary:
EyePoint Pharmaceuticals TTM interest expense is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$2.03 million (-100.00%). EYPT TTM interest expense is now -100.00% below its all-time high of $7.21 million, reached on 31 December 2020.EYPT TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.9% | 0.0% | -100.0% |
| 3 y3 years | -82.8% | -100.0% | -100.0% |
| 5 y5 years | -24.1% | -100.0% | -100.0% |
EYPT Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -82.8% | at low | -100.0% | -100.0% | ||
| 5 y | 5 years | -82.8% | at low | -100.0% | -100.0% | ||
| alltime | all time | -82.8% | -100.0% | -100.0% |
EyePoint Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2024 | - | $0.00(0.0%) | $435.00 K(-65.1%) |
| Dec 2023 | $1.25 M(-60.9%) | $0.00(0.0%) | $1.25 M(-38.5%) |
| Sept 2023 | - | $0.00(-100.0%) | $2.03 M(-24.6%) |
| June 2023 | - | $435.00 K(-46.4%) | $2.69 M(-4.2%) |
| Mar 2023 | - | $812.00 K(+4.0%) | $2.81 M(-12.0%) |
| Dec 2022 | $3.19 M(-42.0%) | $781.00 K(+18.0%) | $3.19 M(-16.0%) |
| Sept 2022 | - | $662.00 K(+19.9%) | $3.80 M(-16.1%) |
| June 2022 | - | $552.00 K(-53.8%) | $4.52 M(-15.4%) |
| Mar 2022 | - | $1.19 M(-14.0%) | $5.35 M(-2.8%) |
| Dec 2021 | $5.50 M(-24.2%) | $1.39 M(0.0%) | $5.50 M(-7.4%) |
| Sept 2021 | - | $1.39 M(+0.9%) | $5.94 M(-7.1%) |
| June 2021 | - | $1.38 M(+2.2%) | $6.39 M(-6.3%) |
| Mar 2021 | - | $1.35 M(-26.3%) | $6.82 M(-5.3%) |
| Dec 2020 | $7.26 M | $1.83 M(-0.9%) | $7.21 M(+0.6%) |
| Sept 2020 | - | $1.84 M(+2.1%) | $7.17 M(+1.0%) |
| June 2020 | - | $1.81 M(+4.4%) | $7.09 M(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $1.73 M(-3.2%) | $6.89 M(+11.5%) |
| Dec 2019 | $6.18 M(+276.1%) | $1.79 M(+1.0%) | $6.18 M(+40.7%) |
| Sept 2019 | - | $1.77 M(+10.7%) | $4.39 M(+27.8%) |
| June 2019 | - | $1.60 M(+56.8%) | $3.43 M(+87.1%) |
| Mar 2019 | - | $1.02 M(+25.2%) | $1.83 M(+125.2%) |
| Dec 2018 | $1.64 M(+128.1%) | - | - |
| Sept 2018 | - | $815.00 K(>+9900.0%) | $815.00 K(>+9900.0%) |
| June 2018 | $720.00 K(>+9900.0%) | - | - |
| Sept 2017 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2017 | $0.00(0.0%) | - | - |
| June 2016 | $0.00(-100.0%) | - | - |
| Mar 2013 | - | $0.00(-100.0%) | $2000.00(0.0%) |
| Dec 2012 | - | $1000.00(0.0%) | $2000.00(+100.0%) |
| Sept 2012 | - | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) |
| June 2012 | $1000.00(-92.3%) | - | - |
| Dec 2011 | - | $0.00 | $0.00 |
| June 2011 | $13.00 K(>+9900.0%) | - | - |
| June 2009 | $0.00(-100.0%) | - | - |
| June 2008 | $507.00 K | - | - |
FAQ
- What is EyePoint Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual interest expense year-on-year change?
- What is EyePoint Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly interest expense year-on-year change?
- What is EyePoint Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals TTM interest expense year-on-year change?
What is EyePoint Pharmaceuticals annual interest expense?
The current annual interest expense of EYPT is $1.25 M
What is the all time high annual interest expense for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual interest expense is $7.26 M
What is EyePoint Pharmaceuticals annual interest expense year-on-year change?
Over the past year, EYPT annual interest expense has changed by -$1.94 M (-60.90%)
What is EyePoint Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of EYPT is $0.00
What is the all time high quarterly interest expense for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly interest expense is $1.84 M
What is EyePoint Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, EYPT quarterly interest expense has changed by $0.00 (0.00%)
What is EyePoint Pharmaceuticals TTM interest expense?
The current TTM interest expense of EYPT is $0.00
What is the all time high TTM interest expense for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high TTM interest expense is $7.21 M
What is EyePoint Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, EYPT TTM interest expense has changed by -$2.03 M (-100.00%)